- Decrease font
- Increase font
- Send to a friend
Click here to bookmark this page
Customize your Bookmarks:
- Type the name of the page the way you would like it to appear in "My Bookmarks";
- Click in the "Add as My Bookmarks" button.
To choose your favorite sessions, please click here.
Centro de Patologia Clínica Ltda. acquisition
Fleury S.A. ("Grupo Fleury" or "Company"), pursuant to paragraph 4 of article 157 of Law 6,404/76 and CVM Instruction 358/02, informs its shareholders and the market in general that, on this date, Fleury Centro de Procedimentos Médicos Avançados S.A., a Company’s subsidiary, has entered into a Sales and Purchase Agreement of Shares, to acquire 100% of the common shares of Centro de Patologia Clínica Ltda. ("CPC").
CPC is a traditional company of the clinical analysis segment with 7 patient service centers in the Metropolitan Region of Natal, state of Rio Grande do Norte. The estimated gross revenue of CPC, of the last 12 months ended in August 2019, reached R$ 13.8 million.
This acquisition will allow Grupo Fleury to reinforce its growth strategy and to strength even more its presence in the Metropolitan Region of Natal, initiating the offer a complete portfolio, including diagnostic services of clinical analysis and diagnostic imaging already present in the brand of Instituto de Radiologia de Natal ("IRN").
The CPC acquisition amount is of R$ 12,000,000.00 (twelve million reais) before deduction and adjustments.
This acquisition does not require the resolution of the Company’s shareholders, in view of the terms of item 7.3 of the Circular Letter CVM/SEP/No. 03/2019.